Sign in
MIST Stock Price, Chart, Stats & News
Milestone Pharmaceuticals Inc.
Save
109.08M
Market cap
–
Current P/E
–
Forward P/E
MIST chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 96.18% |
Operating margin | -4041.72% |
Pretax margin | -4101.10% |
Net margin | -4078.78% |
Effective tax rate | 0.26% |
ROA | -55.53% |
ROE | -656.82% |
D/E | 1.40x |
Interest coverage ratio | -16.28x |
MIST valuation
P/E | – |
P/S | 57.78x |
P/B | 2.09x |
P/CF | -1.78x |
P/FCF | -1.82x |
P/OCF | -1.78x |
PEG | -0.29x |
EV multiple | -1.73x |
About
Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, specializing in the creation and commercialization of cardiovascular therapeutics. Their flagship product, etripamil, an innovative channel blocker, is currently in advanced clinical development. It is undergoing Phase III trials for the treatment of paroxysmal supraventricular tachycardia (PSVT) in the United States and Canada, while also progressing through Phase II trials for atrial fibrillation and rapid ventricular rate.
Similar securities
Based on sector and market capitalization
Report issue